3-(4-((3AR,9bR)-9-methoxy-1,3a,4,9b-tetrahydrochromeno[3,4-c]pyrrol-2(3H)-yl)butyl)-8-phenylpyrazino[2',3':4,5]thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione

InChIKey	`WDTAYDBPNYFWDR-UHFFFAOYSA-N`
Compound Name	3-(4-((3AR,9bR)-9-methoxy-1,3a,4,9b-tetrahydrochromeno[3,4-c]pyrrol-2(3H)-yl)butyl)-8-phenylpyrazino[2',3':4,5]thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione
Canonical SMILES	`COc1cccc2c1C1CN(CCCCn3c(=O)[nH]c4c(sc5ncc(-c6ccccc6)nc54)c3=O)CC1CO2`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Cross-Family
Avg pChEMBL	7.65
Source	BindingDB;ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P25100	ADRA1D	Homo sapiens	Human	PF00001	9.0	Ki	BindingDB
P35368	ADRA1B	Homo sapiens	Human	PF00001	7.6	Ki	BindingDB
Q9C0B1	FTO	Homo sapiens	Human	PF12934 PF12933	6.3	IC50	ChEMBL